- Home
- RGEN vs LCID Comparison
RGEN vs LCID Comparison
Compare RGEN & LCID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- LCID
- Stock Information
- Founded
- RGEN 1981
- LCID 2007
- Country
- RGEN United States
- LCID United States
- Employees
- RGEN N/A
- LCID N/A
- Industry
- RGEN Medical/Dental Instruments
- LCID Auto Manufacturing
- Sector
- RGEN Health Care
- LCID Consumer Discretionary
- Exchange
- RGEN Nasdaq
- LCID Nasdaq
- Market Cap
- RGEN 7.6B
- LCID 9.0B
- IPO Year
- RGEN N/A
- LCID N/A
- Fundamental
- Price
- RGEN $156.55
- LCID $2.96
- Analyst Decision
- RGEN Buy
- LCID Hold
- Analyst Count
- RGEN 12
- LCID 9
- Target Price
- RGEN $187.44
- LCID $3.18
- AVG Volume (30 Days)
- RGEN 470.1K
- LCID 100.3M
- Earning Date
- RGEN 02-19-2025
- LCID 02-25-2025
- Dividend Yield
- RGEN N/A
- LCID N/A
- EPS Growth
- RGEN N/A
- LCID N/A
- EPS
- RGEN N/A
- LCID N/A
- Revenue
- RGEN $633,513,000.00
- LCID $730,510,000.00
- Revenue This Year
- RGEN $2.28
- LCID $33.01
- Revenue Next Year
- RGEN $9.88
- LCID $84.40
- P/E Ratio
- RGEN N/A
- LCID N/A
- Revenue Growth
- RGEN N/A
- LCID 4.98
- 52 Week Low
- RGEN $113.50
- LCID $1.93
- 52 Week High
- RGEN $211.13
- LCID $4.43
- Technical
- Relative Strength Index (RSI)
- RGEN 60.07
- LCID 53.11
- Support Level
- RGEN $149.15
- LCID $2.85
- Resistance Level
- RGEN $160.64
- LCID $3.64
- Average True Range (ATR)
- RGEN 5.96
- LCID 0.28
- MACD
- RGEN 0.91
- LCID -0.04
- Stochastic Oscillator
- RGEN 79.57
- LCID 13.92
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About LCID Lucid Group Inc.
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.